These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31101909)

  • 1. Dipeptidyl peptidase-4 plays a pathogenic role in BSA-induced kidney injury in diabetic mice.
    Takagaki Y; Shi S; Katoh M; Kitada M; Kanasaki K; Koya D
    Sci Rep; 2019 May; 9(1):7519. PubMed ID: 31101909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of DPP-4 and integrin β1 influences endothelial-to-mesenchymal transition.
    Shi S; Srivastava SP; Kanasaki M; He J; Kitada M; Nagai T; Nitta K; Takagi S; Kanasaki K; Koya D
    Kidney Int; 2015 Sep; 88(3):479-89. PubMed ID: 25830763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for antifibrotic incretin-independent effects of the DPP-4 inhibitor linagliptin.
    Zeisberg M; Zeisberg EM
    Kidney Int; 2015 Sep; 88(3):429-31. PubMed ID: 26323066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Saxagliptin reduces renal tubulointerstitial inflammation, hypertrophy and fibrosis in diabetes.
    Gangadharan Komala M; Gross S; Zaky A; Pollock C; Panchapakesan U
    Nephrology (Carlton); 2016 May; 21(5):423-31. PubMed ID: 26375854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FSP1-specific SMAD2 knockout in renal tubular, endothelial, and interstitial cells reduces fibrosis and epithelial-to-mesenchymal transition in murine STZ-induced diabetic nephropathy.
    Loeffler I; Liebisch M; Allert S; Kunisch E; Kinne RW; Wolf G
    Cell Tissue Res; 2018 Apr; 372(1):115-133. PubMed ID: 29209813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hibiscus sabdariffa polyphenols alleviate insulin resistance and renal epithelial to mesenchymal transition: a novel action mechanism mediated by type 4 dipeptidyl peptidase.
    Peng CH; Yang YS; Chan KC; Wang CJ; Chen ML; Huang CN
    J Agric Food Chem; 2014 Oct; 62(40):9736-43. PubMed ID: 25226384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury.
    Penno G; Garofolo M; Del Prato S
    Nutr Metab Cardiovasc Dis; 2016 May; 26(5):361-73. PubMed ID: 27105869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sitagliptin ameliorates renal tubular injury in diabetic kidney disease via STAT3-dependent mitochondrial homeostasis through SDF-1α/CXCR4 pathway.
    Zhang Q; He L; Dong Y; Fei Y; Wen J; Li X; Guan J; Liu F; Zhou T; Li Z; Fan Y; Wang N
    FASEB J; 2020 Jun; 34(6):7500-7519. PubMed ID: 32281218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
    Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
    Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More than just an enzyme: Dipeptidyl peptidase-4 (DPP-4) and its association with diabetic kidney remodelling.
    Gupta S; Sen U
    Pharmacol Res; 2019 Sep; 147():104391. PubMed ID: 31401210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose-independent renoprotective mechanisms of the tissue dipeptidyl peptidase-4 inhibitor, saxagliptin, in Dahl salt-sensitive hypertensive rats.
    Uchii M; Kimoto N; Sakai M; Kitayama T; Kunori S
    Eur J Pharmacol; 2016 Jul; 783():56-63. PubMed ID: 27063445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis.
    Srivastava SP; Shi S; Kanasaki M; Nagai T; Kitada M; He J; Nakamura Y; Ishigaki Y; Kanasaki K; Koya D
    Sci Rep; 2016 Jul; 6():29884. PubMed ID: 27425816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes.
    Kodera R; Shikata K; Takatsuka T; Oda K; Miyamoto S; Kajitani N; Hirota D; Ono T; Usui HK; Makino H
    Biochem Biophys Res Commun; 2014 Jan; 443(3):828-33. PubMed ID: 24342619
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs.
    Srivastava SP; Goodwin JE; Kanasaki K; Koya D
    Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32085655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-1, a binding protein of CD26, is essential for the anti-inflammatory effects of dipeptidyl peptidase-4 inhibitors on human and mouse macrophages.
    Hiromura M; Nohtomi K; Mori Y; Kataoka H; Sugano M; Ohnuma K; Kuwata H; Hirano T
    Biochem Biophys Res Commun; 2018 Jan; 495(1):223-229. PubMed ID: 29113797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Dipeptidyl Peptidase-4 Inhibitor and Angiotensin-Converting Enzyme Inhibitor on Experimental Diabetic Kidney Disease.
    Al Tuhaifi T; Zhong J; Yang HC; Fogo AB
    Lab Invest; 2024 Feb; 104(2):100305. PubMed ID: 38109999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipeptidyl peptidase-4 inhibitor teneligliptin accelerates recovery from cisplatin-induced acute kidney injury by attenuating inflammation and promoting tubular regeneration.
    Iwakura T; Zhao Z; Marschner JA; Devarapu SK; Yasuda H; Anders HJ
    Nephrol Dial Transplant; 2019 Oct; 34(10):1669-1680. PubMed ID: 30624740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linagliptin-mediated DPP-4 inhibition ameliorates kidney fibrosis in streptozotocin-induced diabetic mice by inhibiting endothelial-to-mesenchymal transition in a therapeutic regimen.
    Kanasaki K; Shi S; Kanasaki M; He J; Nagai T; Nakamura Y; Ishigaki Y; Kitada M; Srivastava SP; Koya D
    Diabetes; 2014 Jun; 63(6):2120-31. PubMed ID: 24574044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel DPP-4 inhibitor teneligliptin scavenges hydroxyl radicals: In vitro study evaluated by electron spin resonance spectroscopy and in vivo study using DPP-4 deficient rats.
    Kimura S; Inoguchi T; Yamasaki T; Yamato M; Ide M; Sonoda N; Yamada K; Takayanagi R
    Metabolism; 2016 Mar; 65(3):138-45. PubMed ID: 26892525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Linagliptin but not Sitagliptin inhibited transforming growth factor-β2-induced endothelial DPP-4 activity and the endothelial-mesenchymal transition.
    Shi S; Kanasaki K; Koya D
    Biochem Biophys Res Commun; 2016 Feb; 471(1):184-90. PubMed ID: 26826382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.